These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27682231)

  • 1. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
    Uchida T; Mori M; Uzawa A; Masuda H; Muto M; Ohtani R; Kuwabara S
    Mult Scler; 2017 Jul; 23(8):1072-1084. PubMed ID: 27682231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
    Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.
    Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N
    J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum matrix metalloproteinase-9 in neuromyelitis optica: implication of disruption of blood-brain barrier.
    Hosokawa T; Nakajima H; Doi Y; Sugino M; Kimura F; Hanafusa T; Takahashi T
    J Neuroimmunol; 2011 Jul; 236(1-2):81-6. PubMed ID: 21621856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
    Jarius S; Franciotta D; Paul F; Ruprecht K; Bergamaschi R; Rommer PS; Reuss R; Probst C; Kristoferitsch W; Wandinger KP; Wildemann B
    J Neuroinflammation; 2010 Sep; 7():52. PubMed ID: 20825655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
    Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral and cellular immune responses in neuromyelitis optica].
    Kawachi I
    Rinsho Shinkeigaku; 2010 Nov; 50(11):873-4. PubMed ID: 21921483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
    Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
    PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Masuda H; Mori M; Uchida T; Uzawa A; Ohtani R; Kuwabara S
    J Neuroimmunol; 2017 Apr; 305():102-107. PubMed ID: 28284329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
    Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
    Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disruption of blood-brain barrier in multiple sclerosis and neuromyelitis optica].
    Shimizu F; Kanda T
    Nihon Rinsho; 2014 Nov; 72(11):1949-54. PubMed ID: 25518376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Sawai S; Kuwabara S
    Clin Chim Acta; 2017 Jun; 469():144-149. PubMed ID: 28283439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of inflammation in neuromyelitis optica spectrum disorders.
    Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
    Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
    Bennett JL; Lam C; Kalluri SR; Saikali P; Bautista K; Dupree C; Glogowska M; Case D; Antel JP; Owens GP; Gilden D; Nessler S; Stadelmann C; Hemmer B
    Ann Neurol; 2009 Nov; 66(5):617-29. PubMed ID: 19938104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.
    Guo Y; Weigand SD; Popescu BF; Lennon VA; Parisi JE; Pittock SJ; Parks NE; Clardy SL; Howe CL; Lucchinetti CF
    Acta Neuropathol; 2017 Apr; 133(4):597-612. PubMed ID: 28184993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica.
    Mandler RN; Dencoff JD; Midani F; Ford CC; Ahmed W; Rosenberg GA
    Brain; 2001 Mar; 124(Pt 3):493-8. PubMed ID: 11222449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.